Literature DB >> 33732261

Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19.

Maxim Shkurnikov1, Stepan Nersisyan1, Tatjana Jankevic2, Alexei Galatenko1,3, Ivan Gordeev2,4, Valery Vechorko4, Alexander Tonevitsky1,5.   

Abstract

Human leukocyte antigen (HLA) class I molecules play a crucial role in the development of a specific immune response to viral infections by presenting viral peptides at the cell surface where they will be further recognized by T cells. In the present manuscript, we explored whether HLA class I genotypes can be associated with the critical course of Coronavirus Disease-19 by searching possible connections between genotypes of deceased patients and their age at death. HLA-A, HLA-B, and HLA-C genotypes of n = 111 deceased patients with COVID-19 (Moscow, Russia) and n = 428 volunteers were identified with next-generation sequencing. Deceased patients were split into two groups according to age at the time of death: n = 26 adult patients aged below 60 and n = 85 elderly patients over 60. With the use of HLA class I genotypes, we developed a risk score (RS) which was associated with the ability to present severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) peptides by the HLA class I molecule set of an individual. The resulting RS was significantly higher in the group of deceased adults compared to elderly adults [p = 0.00348, area under the receiver operating characteristic curve (AUC ROC = 0.68)]. In particular, presence of HLA-A*01:01 allele was associated with high risk, while HLA-A*02:01 and HLA-A*03:01 mainly contributed to low risk. The analysis of patients with homozygosity strongly highlighted these results: homozygosity by HLA-A*01:01 accompanied early deaths, while only one HLA-A*02:01 homozygote died before 60 years of age. Application of the constructed RS model to an independent Spanish patients cohort (n = 45) revealed that the score was also associated with the severity of the disease. The obtained results suggest the important role of HLA class I peptide presentation in the development of a specific immune response to COVID-19.
Copyright © 2021 Shkurnikov, Nersisyan, Jankevic, Galatenko, Gordeev, Vechorko and Tonevitsky.

Entities:  

Keywords:  COVID-19; HLA class I; MHC class I; SARS-CoV-2; peptide presentation

Mesh:

Substances:

Year:  2021        PMID: 33732261      PMCID: PMC7959787          DOI: 10.3389/fimmu.2021.641900

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  34 in total

1.  The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage.

Authors:  Morten Nielsen; Claus Lundegaard; Ole Lund; Can Keşmir
Journal:  Immunogenetics       Date:  2005-03-03       Impact factor: 2.846

2.  Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection.

Authors:  R J Mazzaccaro; M Gedde; E R Jensen; H M van Santen; H L Ploegh; K L Rock; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

3.  [Epidemiology of Arterial Hypertension in Russian Federation - Importance of Choice of Criteria of Diagnosis].

Authors:  A M Erina; O P Rotar; V N Solntsev; S A Shalnova; A D Deev; E I Baranova; O A Konradi; S A Boytsov; E V Shlyakhto
Journal:  Kardiologiia       Date:  2019-06-25       Impact factor: 0.395

4.  Clustal Omega for making accurate alignments of many protein sequences.

Authors:  Fabian Sievers; Desmond G Higgins
Journal:  Protein Sci       Date:  2017-10-30       Impact factor: 6.725

5.  Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2.

Authors:  Austin Nguyen; Julianne K David; Sean K Maden; Mary A Wood; Benjamin R Weeder; Abhinav Nellore; Reid F Thompson
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

6.  Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19).

Authors:  Wei Wang; Wei Zhang; Jingjing Zhang; Ji He; Faming Zhu
Journal:  HLA       Date:  2020-06-02       Impact factor: 8.762

7.  Association of human-leukocyte-antigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome.

Authors:  Margaret H L Ng; Kin-Mang Lau; Libby Li; Suk-Hang Cheng; Wing Y Chan; Pak K Hui; Benny Zee; Chi-Bon Leung; Joseph J Y Sung
Journal:  J Infect Dis       Date:  2004-07-07       Impact factor: 5.226

8.  IPD-IMGT/HLA Database.

Authors:  James Robinson; Dominic J Barker; Xenia Georgiou; Michael A Cooper; Paul Flicek; Steven G E Marsh
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

9.  Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus-receptor binding.

Authors:  Pia Gattinger; Kristina Borochova; Yulia Dorofeeva; Rainer Henning; Renata Kiss; Bernhard Kratzer; Bernhard Mühl; Thomas Perkmann; Doris Trapin; Martina Trella; Paul Ettel; Inna Tulaeva; Winfried F Pickl; Rudolf Valenta
Journal:  Allergy       Date:  2020-07-30       Impact factor: 13.146

10.  Clinical and epidemiological characteristics of 320 deceased patients with COVID-19 in an Italian Province: A retrospective observational study.

Authors:  Andrea Biagi; Luca Rossi; Alessandro Malagoli; Alessia Zanni; Concetta Sticozzi; Greta Comastri; Stefano Gandolfi; Giovanni Quinto Villani
Journal:  J Med Virol       Date:  2020-06-29       Impact factor: 20.693

View more
  35 in total

1.  SARS-CoV-2 Host Immunogenetic Biomarkers.

Authors:  Maemu P Gededzha; Nakampe Mampeule; Anastasia Gandini; Elizabeth S Mayne
Journal:  Methods Mol Biol       Date:  2022

2.  Genetic polymorphisms associated with susceptibility to COVID-19 disease and severity: A systematic review and meta-analysis.

Authors:  Cristine Dieter; Letícia de Almeida Brondani; Cristiane Bauermann Leitão; Fernando Gerchman; Natália Emerim Lemos; Daisy Crispim
Journal:  PLoS One       Date:  2022-07-06       Impact factor: 3.752

3.  Molecular Analysis of SARS-CoV-2 Lineages in Armenia.

Authors:  Diana Avetyan; Siras Hakobyan; Maria Nikoghosyan; Lilit Ghukasyan; Gisane Khachatryan; Tamara Sirunyan; Nelli Muradyan; Roksana Zakharyan; Andranik Chavushyan; Varduhi Hayrapetyan; Anahit Hovhannisyan; Shah A Mohamed Bakhash; Keith R Jerome; Pavitra Roychoudhury; Alexander L Greninger; Lyudmila Niazyan; Mher Davidyants; Gayane Melik-Andreasyan; Shushan Sargsyan; Lilit Nersisyan; Arsen Arakelyan
Journal:  Viruses       Date:  2022-05-17       Impact factor: 5.818

4.  Modeling recapitulates the heterogeneous outcomes of SARS-CoV-2 infection and quantifies the differences in the innate immune and CD8 T-cell responses between patients experiencing mild and severe symptoms.

Authors:  Budhaditya Chatterjee; Harshbir Singh Sandhu; Narendra M Dixit
Journal:  PLoS Pathog       Date:  2022-06-27       Impact factor: 7.464

Review 5.  The human genetic epidemiology of COVID-19.

Authors:  Mari E K Niemi; Mark J Daly; Andrea Ganna
Journal:  Nat Rev Genet       Date:  2022-05-02       Impact factor: 59.581

6.  HLA repertoire of 115 UAE nationals infected with SARS-CoV-2.

Authors:  Halima Alnaqbi; Guan K Tay; Herbert F Jelinek; Amirtharaj Francis; Eman Alefishat; Sarah El Haj Chehadeh; Amna Tahir Saeed; Mawada Hussein; Bassam H Mahboub; Maimunah Uddin; Nawal Alkaabi; Habiba S Alsafar
Journal:  Hum Immunol       Date:  2021-08-21       Impact factor: 2.850

Review 7.  Relevance Between COVID-19 and Host Genetics of Immune Response.

Authors:  Ibrahim Taher; Abdulrahman Almaeen; Amany Ghazy; Mohamed Abu-Farha; Arshad Mohamed Channanath; Sumi Elsa John; Prashantha Hebbar; Hossein Arefanian; Jehad Abubaker; Fahd Al-Mulla; Thangavel Alphonse Thanaraj
Journal:  Saudi J Biol Sci       Date:  2021-07-17       Impact factor: 4.219

8.  HLA-C*17 in COVID-19 patients: Hints for associations with severe clinical outcome and cardiovascular risk.

Authors:  Irene Bonaccorsi; Paolo Carrega; Emmanuele Venanzi Rullo; Rosaria Ducatelli; Michela Falco; Josè Freni; Massimiliano Miceli; Riccardo Cavaliere; Vincenzo Fontana; Antonio Versace; Gaetano Caramori; Antonio David; Giuseppe Nunnari; Guido Ferlazzo
Journal:  Immunol Lett       Date:  2021-04-24       Impact factor: 3.685

9.  Host polymorphisms and COVID-19 infection.

Authors:  Joris R Delanghe; Marijn M Speeckaert
Journal:  Adv Clin Chem       Date:  2021-08-23       Impact factor: 5.394

Review 10.  Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2.

Authors:  Pankaj Ahluwalia; Kumar Vaibhav; Meenakshi Ahluwalia; Ashis K Mondal; Nikhil Sahajpal; Amyn M Rojiani; Ravindra Kolhe
Journal:  Front Immunol       Date:  2021-05-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.